|
Server : Apache/2.4.62 System : FreeBSD fbsdweb2.web.rcn.net 14.1-RELEASE FreeBSD 14.1-RELEASE releng/14.1-n267679-10e31f0946d8 GENERIC amd64 User : www ( 80) PHP Version : 8.3.8 Disable Function : NONE Directory : /domains/bluerae/clients/abs/pub/ |
Upload File : |
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<title>Presentations: ABS Abt Bio-Pharma Solutions</title>
<script language="javascript" type="text/javascript" src="../scripts/scripts.js"></script>
<link href="../styles/styles.css" rel="stylesheet" type="text/css" />
</head>
<body onload="P7_autoHide('popupabout','popupadvantage','popupservices','popuppub','popupnews','popupcareers');MM_preloadImages('../images/thumb1_ovr.jpg','../images/thumb2_ovr.jpg','../images/thumb3_ovr.jpg','../images/ba_about.gif','../images/ba_advantage.gif','../images/ba_services.gif','../images/ba_pub.gif','../images/ba_news.gif','../images/ba_careers.gif')">
<div id="container">
<a name="top"></a>
<!--HEADER-->
<div id="header" onmouseover="P7_autoLayers(0)"><p><a href="../index.html"><img src="../images/logo.gif" alt="ABS: Abt Bio-Pharma Solutions" width="284" height="85" id="logo" /></a><a href="../index.html">home</a> :: <a href="../about/our.html">contact us</a> :: <a href="../search/index.html">search</a> :: <a href="../sitemap/index.html">sitemap</a></p>
<img src="../images/tagline.gif" alt="Real World. Real Value." width="240" height="20" class="tagline" />
</div>
<!--MAIN MENU-->
<div id="mainmenu"><img src="../images/menu_cap.gif" alt=" " onmouseover="P7_autoLayers(0)" /><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('about','','../images/ba_about.gif',1)"><img src="../images/b_about.gif" alt="About Us" name="about" width="81" height="35" border="0" id="about" onmouseover="P7_autoLayers(0,'popupabout');P7_Snap('about','popupabout',0,35)" /></a><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('advantage','','../images/ba_advantage.gif',1)"><img src="../images/b_advantage.gif" alt="ABS Advantage" name="advantage" width="123" height="35" border="0" id="advantage" onmouseover="P7_autoLayers(0,'popupadvantage');P7_Snap('advantage','popupadvantage',0,35)" /></a><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('services','','../images/ba_services.gif',1)"><img src="../images/b_services.gif" alt="Services" name="services" width="81" height="35" border="0" id="services" onmouseover="P7_autoLayers(0,'popupservices');P7_Snap('services','popupservices',0,35)" /></a><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('pub','','../images/ba_pub.gif',1)"><img src="../images/ba_pub.gif" alt="Publications & Presentations" name="pub" width="221" height="35" border="0" id="pub" onmouseover="P7_autoLayers(0,'popuppub');P7_Snap('pub','popuppub',0,35)" /></a><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('news','','../images/ba_news.gif',1)"><img src="../images/b_news.gif" alt="News & Events" name="news" width="120" height="35" border="0" id="news" onmouseover="P7_autoLayers(0,'popupnews');P7_Snap('news','popupnews',0,35)" /></a><a href="#" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('careers','','../images/ba_careers.gif',1)"><img src="../images/b_careers.gif" alt="Careers" name="careers" width="80" height="35" border="0" id="careers" onmouseover="P7_autoLayers(0,'popupcareers');P7_Snap('careers','popupcareers',0,35)" /></a><img src="../images/menu_cap.gif" alt=" " /></div>
<div id="sidebarleft"><div id="pagemenu">
<ul>
<li><a href="publications.html">Publications</a></li>
<li><a href="presentations.html" class="selected">Presentations</a></li>
<ul>
<li><a href="#2008">2008</a></li>
<li><a href="#2007">2007</a></li>
<li><a href="#2006">2006</a></li>
<li><a href="#2005">2005</a></li>
<li><a href="#2004">2004</a></li>
</ul>
</ul>
</div>
</div>
<!-- SIDEBAR -->
<div id="sidebar"><form action="http://search.freefind.com/find.html" method="get" accept-charset="utf-8" target="_self">
<p>
<input type="hidden" name="si" value="49467390">
<input type="hidden" name="pid" value="r">
<input type="hidden" name="n" value="0">
<input type="hidden" name="_charset_" value="">
<input type="hidden" name="bcd" value="÷">
<input type="text" name="query" class="searchfield" onfocus="clearText(this);clearStyle(this);" value="SEARCH" size="20">
<input type="image" name="submit" id="submit" src="../images/go.gif" /> </p>
</form><h1 class="sidebarhead"> </h1>
<ul class="sidebarlist">
<li class="quote">"The complex biopharma marketplace requires a comprehensive approach to commercialization. We understand that, and have developed a holistic perspective that addresses an increasingly dynamic healthcare marketplace when designing research methodologies and interpreting result." </li>
</ul>
<p class="attribution">Nandini Hadker, Executive Director, Abt Bio-Pharma Solutions, Inc.</p>
</div>
<!-- MAIN CONTENT -->
<div id="maincontent" class="prominentlinks">
<h1>Presentations</h1>
<p>The following are selected presentations of ABS Team Members:</p>
<a name="2008"></a>
<h2>2008</h2>
<p>Miller JD, Denevich S, McGarry MJ, Albano
MP, Caloyeras JP, Russell MW. <strong><a href="../downloads/Miller_ModelingImagingOct08.pdf">Modeling the fiscal impact of using perflutren lipid
microspheres (PLM) for follow-up echocardiographic imaging.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008. </p>
<p>
Ganz ML, Prasad M, Yeh YC, Miller JD,
Russell MW. <strong>Initial combination therapy with infliximab versus
sequential DMARD monotherapy: a cost-effectiveness model based on the BeST
study.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008. </p>
<p>
Ganz ML, Smalarz AM, Anger JT, Krupski TL,
Hu JC, Wittrup-Jensen KU, Pashos CL. <strong>Cost of overactive bladder in the United States.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008. </p>
<p>
Zhao Y, Boulanger L, Wu N, Lamothe K,
Russell MW. <strong>Healthcare resource use and costs among patients
with diabetic neuropathic pain in the one-year following duloxetine therapy:
is initial dosing a significant factor?</strong> International Society for Pharmacoeconomics and
Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008. </p>
<p>
Brown TM, Lee WC, Joshi AV, Pashos CL. <strong>Health-related quality of life and productivity
among hemophilia patients with inhibitors.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 11th Annual European Congress, Athens, Greece, November 8-11, 2008. </p>
<p>
Larholt K, Burton T, Boulanger L, et al. <strong><a href="../downloads/Larholt_TransfusionOutcomesASCOMay08.pdf">Transfusion outcomes in erythropoiesis-stimulating
agent (ESA)-treated cancer chemotherapy patients based on achieved hemoglobin
(Hb) levels.</a></strong> American Society of Clinical Oncology, 44th Annual Meeting, Chicago, IL, May 30-June 3, 2008. </p>
<p>
Ganz ML, Pashos CL, Joshi AV, Wang Q, Lee
WC, Wilke CT. <strong><a href="../downloads/Ganz_ClinicalandEconomicOutcomesMay08.pdf">Clinical and economic outcomes associated with
bleeding during coronary artery bypass graft surgery among elderly Americans.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
<p>
Burton T, Larholt K, Hoaglin D, Pashos CL,
Bookhart B, Corral M, McKenzie RS, Tak Piech, C. <strong><a href="../downloads/Burton_CllinicalOutcomesMay08.pdf">Clinical outcomes and drug cost in
erythropoiesis-stimulating agent (ESA)-treated cancer chemotherapy patients
initiated with baseline (BL) hemoglobin.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
<p>
Lee WC, Brown M, Joshi AV, Foster T,
Pashos CL. <strong>The perspective of patients with hemophilia with
inhibitors and their care givers: Preferences for treatment characteristics.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
<p>
Lee WC, Brown M, Joshi AV, Foster T,
Pashos CL. <strong>Health-related quality of life of patients with
hemophilia and inhibitors.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
<p>
Gao X, Shah S, Reddy P, Gondek K, Pashos
CL. <strong><a href="../downloads/Gao_EconomicEvaluationMay08.pdf">Economic evaluation of sorafenib versus best
supportive care in advanced renal cell carcinoma: an updated
cost-effectiveness analysis.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
<p>
Boulanger L, Doan J, Pashos CL. <strong><a href="../downloads/Boulanger_SubstanceAbuseMay08.pdf">Substance abuse among patients diagnosed with
insomnia.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
<p>
Boulanger L, Mody R, Bao Y, Ancukiewicz V,
Kothari-Talwar S, Russell MW. <strong>Does the dosing frequency of proton pump inhibitors
(PPIs) affect subsequent resource utilization and costs among patients
diagnosed with gastroesophageal reflux disease (GERD)?</strong> International Society for Pharmacoeconomics and
Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
<p>
Lee WC, Pickard S, Wilke C, Joshi AV, Yeh
YC, Wang Q, Pashos CL. <strong>Economic impact of stroke-related comorbid
conditions on the treatment of stroke: an analysis of Medicare beneficiaries
in the United States.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
<p>
Gao X, Spalding JR, Denevich S, Reddy P. <strong><a href="../downloads/Gao_GenderDisparitiesMay08.pdf">Gender disparities in the utilization of myocardial
perfusion imaging.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
<p>
Boulanger L, Zhao Y, Bao Y, Cai C, Ye W,
Russell, MW. <strong>Factors associated with healthcare costs among
elderly patients with diabetic neuropathy. </strong>International Society for Pharmacoeconomics and
Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
<p>
Caloyeras JP, Wang C, Bauer L, Lee WC,
Lanius V, Gondek K. <strong><a href="../downloads/Caloyeras_CostUtilityInterferonMay08.pdf">Cost-utility of Interferon Beta-1b in the treatment
of patients with a clinically isolated syndrome suggestive of multiple
sclerosis.</a> </strong>International Society for Pharmacoeconomics and
Outcomes Research, 13th Annual International Meeting, Toronto, Canada, May 3-7, 2008. </p>
<p>
Larholt K et al. <strong>Transfusion outcomes among oncology patients
initiated with Erythropoiesis-Stimulating Agents (ESAs) at baseline
hemoglobin (Hb) of <10 v 10- 11 g/dL: Observational data from the Dosing
and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) Registry.</strong> Community Oncology Conference, Washington, DC, February 1-3, 2008. </p>
<p>
Larholt K et al. <strong><a href="../downloads/Larholt_HemoLevelsFeb08.pdf">Hemoglobin (Hb) levels prior to blood transfusions
in oncology patients receiving chemotherapy and Erythropoiesis-Stimulating
Agents (ESAs): Observational Data from the Dosing and Outcomes Study of
Erythropoiesis-Stimulating Therapies (DOSE) Registry.</a></strong> Community Oncology Conference, Washington, DC, February 1-3, 2008. </p>
<p class="backtotop"><a href="#top">back to top</a></p>
<a name="2007"></a>
<h2>2007</h2>
<p>
Balu S, Dutcher S, Lee WC, Joshi AV, Bilde
L, Booth F, Pashos CL. <strong>Characterization, risk factors, clinical outcomes,
and economic consequences of bleeding associated with cardiac surgery: A
systematic literature review.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 10th Annual European Congress, Dublin, Ireland, October 20-23, 2007. </p>
<p>
Lee WC, Joshi AV, Pashos CL. <strong>Best-worst case scaling in discrete choice
experiments: An application in a rare disease population.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 10th Annual European Congress, Dublin, Ireland, October 20-23, 2007. </p>
<p>
Balu S, Lee WC, Arondekar B, Horblyuk R,
Pashos CL. <strong>Economic analysis of add-on therapy with
thiazolidinedione (TZD) versus insulin (INS) to metformin (MET) monotherapy.</strong> American Diabetes Association, 67th Scientific Sessions, Chicago, IL, June 22-26, 2007. </p>
<p>
Balu S, Arondekar B, Lee WC, Horblyuk R,
Pashos CL. <strong>Budgetary impact of thiazolidinedione (TZD) add-on
therapy relative to insulin (INS) add-on therapy in individuals treated with
sulfonylureas (SU): A third party payer's perspective. </strong>American Diabetes Association, 67th Scientific Sessions, Chicago, IL, June 22-26, 2007. </p>
<p>
Pashos CL, Wang Q, Larholt K, Bookhart B,
McKenzie RS, Piech CT. <strong><a href="../downloads/Pashos_DrugCostConsiderationsJune07.pdf">Drug cost considerations for erythroprietic
stimulating therapies (ESTs) agents in patients initiated at FDA-approved
dosing: Results from practice patterns in a prospective observational study.</a></strong> Hematology Oncology Pharmacy Association (HOPA), 3rd Annual Conference, Denver, CO, June 14-16, 2007. </p>
<p>
Cai QC, Sullivan P, Yeh YC, Russell M. <strong><a href="../downloads/Cai_Assessing12ASCOJune07.pdf">Assessing 12 or more lymph nodes increases the
proportion of stage III disease in colorectal cancer (CRC): Evidence from the
Surveillance, Epidemiology and End Results (SEER) cancer registry.</a></strong> American Society of Clinical Oncology, 43rd Annual Meeting, Chicago, IL, June 1-5, 2007. </p>
<p>
Yeh YC, Cai QC, Chao J, Russell MW. <strong><a href="../downloads/Yeh_More AggressiveASCOJune07.pdf">Is more aggressive lymph node assessment associated
with improved survival in stage II-III colorectal cancer? Evidence from the
Surveillance, Epidemiology and End Results (SEER) cancer registry.</a> </strong>American Society of Clinical Oncology, 43rd Annual Meeting, Chicago, IL, June 1-5, 2007. </p>
<p>
Lee WC, Balu S, Cobden D, Joshi AV, Pashos
CL. <strong><a href="../downloads/Lee_CopaymentLeveMay07.pdf">Co-payment level and medication adherence in type 2
diabetes patients managed with insulin aspart pen therapy.</a> </strong>International Society for Pharmacoeconomics and
Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007. </p>
<p>
Balu S, Lee WC, Cobden D, Joshi AV, Pashos
CL.<strong> <a href="../downloads/Balu_ImpactofInitiatingMay07.pdf">Impact of initiating or converting to treatment with
an insulin aspart analog pen on medication adherence in type 2 diabetes
patients on vial/syringe insulin.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007. </p>
<p>
Balu S, Dutcher S, Lee WC, Cobden D, Joshi
AV, Pashos CL. <strong><a href="../downloads/Balu_EpidemiologyEconomicBurdenMay07.pdf">Epidemiology and economic burden of stroke-related
risk factors: A systematic literature review. </a></strong>International Society for Pharmacoeconomics and
Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007. </p>
<p>
Boulanger L, Miller JD, MacEachern L,
Reddy P, Russell MW, Pashos CL. <strong><a href="../downloads/Boulanger_PrevalenceCachexiaMay07.pdf">Prevalance of cachexia (wasting syndrome) diagnosis
and treatment among patients with HIV/AIDS: A medical claims database
analysis.</a> </strong>International Society for Pharmacoeconomics and
Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007. </p>
<p>
Pashos CL, Wang Q, Larholt K, Bookhart B,
McKenzie RS, Piech CT. <strong><a href="../downloads/Pashos_DrugCostConsiderationsJune07.pdf">Drug cost considerations for erythroprietic
stimulating therapies (ESTs) agents in patients initiated at FDA-approved
dosing: Results from practice patterns in a prospective observational study.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007. </p>
<p>
Boulanger L, Brown JS. <strong>Methodological considerations in conducting cost of
illness studies employing large administrative claim databases.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 12th Annual International Meeting, Arlington, VA, May 19-23, 2007. </p>
<p>
Lee WC, Yeh YC, Atzinger C, Pashos CL. <strong><a href="../downloads/Lee_ColonoscopyScreeningDDWMay07.pdf">Clinical and economic impact of increased
colonoscopy screening in the United States: A computer simulation of a Markov
process.</a></strong> Digestive Disease Week, Annual Meeting, Washington, DC, May 19-24, 2007. </p>
<p>
Lee WC, Balu S, Cobden D, Joshi AV, Pashos
CL. <strong>Medication adherence and the health economic impact
of anti-diabetic therapy conversion to an insulin analog pen device among
type 2 diabetes patients.</strong> Academy of Managed Care Pharmacy, 19th Annual Meeting, San Diego, CA, April 11-14, 2007. </p>
<p class="backtotop"><a href="#top">back to top</a></p>
<a name="2006"></a>
<h2>2006</h2>
<p>
Chen E, Peake C, Buscaino E, Forlenza J,
Bookhart B, McKenzie S. <strong><a href="../downloads/Chen_HematologicOutcomesDec06.pdf">Hematologic outcomes and erythropoiesis-stimulating
therapy costs in Epoetin Alfa (EPO) and Darbepoetin Alfa (DARB)-treated
cancer patients: Results of the Dosing and Outcomes Study of
Erythropoiesis-Stimulating Therapies (DOSE) Registry.</a></strong> American Society of Hematology, 48th Annual Meeting and Exposition, Orlando, FL, December 9-12, 2006. </p>
<p>
Wang Q, Larholt K, Pashos C, Forlenza J,
Bookhart B, McKenzie S. <strong><a href="../downloads/Wang_EarlyHemoglobinDec06.pdf">Early hemoglobin response to
erythropoiesis-stimulating therapies (ESTs) and outcomes in cancer patients
with anemia: Results from a prospective, observational study.</a></strong> American Society of Hematology, 48th Annual Meeting and Exposition, Orlando, FL, December 9-12, 2006. </p>
<p>
Lee WC, Balu S, Cobden D, Joshi AV, Pashos
CL.<a href="../downloads/Lee_ImprovingAdherenceIDFDec06.pdf"> <strong>Improving medication adherence for type 2 diabetes
patients: Effects of an analog insulin pen device.</strong> </a>International Diabetes Federation, 19th Annual Meeting, Capetown, South Africa, December 3-7, 2006. </p>
<p>
Lee WC, Cobden D, Balu S, Joshi AV, Pashos
CL. <strong><a href="../downloads/Lee_ReducingHypoNov06.pdf">Reducing hypoglycemic events, costs and associated
resource utilization in type 2 diabetes patients with conversion to an analog
insulin pen device.</a></strong> Diabetes Technology Society, 6th Annual Meeting, Atlanta, GA, November 2-4, 2006. </p>
<p>
Lee WC, Cobden D, Balu S, Joshi AV, Pashos
CL. <strong><a href="../downloads/Lee_InsulinAdministrationNov06.pdf">Insulin administration with an analog pen device:
Effect on medication adherence in type 2 diabetes patients.</a></strong> Diabetes Technology Society, 6th Annual Meeting, Atlanta, GA, November 2-4, 2006. </p>
<p>
Lee WC, Balu S, Cobden D, Joshi AV, Pashos
CL. <strong>Insulin therapy among type 2 diabetes patients:
Impact of conversion to a pen device on adherence, hypoglycemic events, and
costs.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006. </p>
<p>
Reddy P, Boci K, Charbonneau C. <strong><a href="../downloads/Reddy_GISTOct2006.pdf">The epidemiologic, health-related quality of life,
and economic burden of gastrointestinal stromal tumors.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006. </p>
<p>
Banks J, Gupta K, Balu S, Chen E,
Komatsuzaki Y, Charbonneau, Pashos CL. <strong>The epidemiologic, humanistic and economic burden of
patients with metastatic renal cell carcinoma.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006. </p>
<p>
Lee WC, Joshi AV, Brown M, Hadker N,
Sumner M, Pashos CL. <strong><a href="../downloads/Lee_CoagulationOct2006.pdf">Physicians’ preferences toward coagulation factor
concentrates in the treatment of hemophilia patients with inhibitors: A
discrete choice experiment.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006. </p>
<p>
Balu S, Lee WC, Joshi AV, Cobden D, Pashos
CL. <strong><a href="../downloads/Balu_AtrophicMay06.pdf">Treatment duration for atrophic vaginitis: Clinical
trials versus “the real world”.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006. </p>
<p>
Balu S, Lee WC, Joshi AV, Cobden D, Pashos
CL. <strong>Underutilization of vaginal estrogen therapy in a
managed care setting.</strong> North American Menopause Society, 17th Annual Meeting, Nashville, TN, October 11-14, 2006. </p>
<p>
Lee WC, Wang Q, Balu S, Joshi AV, Cobden
D, Pashos CL. <strong>Treatment duration and adherence to vaginal estrogen
therapy in patients receiving vaginal tablets versus vaginal creams in a
managed care setting. </strong>North American Menopause Society, 17th Annual Meeting, Nashville, TN, October 11-14, 2006. </p>
<p>
Gao X, Sato R, Nab H, Singh A. <strong><a href="../downloads/Gao_CostEffectivenessJune06.pdf">Cost-effectiveness of TNF inhibitors in the
treatment of rheumatoid arthritis using radiographic progression as the
effectiveness measure in the Netherlands.</a></strong> European Congress of Rheumatology, Annual Meeting, Amsterdam, Netherlands, June 21-24, 2006. </p>
<p>
Gao X, Reddy P, Dhanda R, Gondek K, Yeh
YC, Stadler W, Jonasch E. <strong><a href="../downloads/Gao_CESorafenibASCOJune06.pdf">Cost-effectiveness of sorafenib versus best
supportive care in advanced renal cell carcinoma.</a> </strong>American Society of Clinical Oncology, Annual Meeting, Atlanta, GA, June 2-6, 2006. </p>
<p>
Memisoglu A, Peake C, Buscaino E. <strong>Dosing and Outcomes Study of
Erythropoiesis-Stimulating Therapies (D.O.S.E.) Registry: Analysis of
outcomes and costs of epoetin alfa (EPO) and darbepoetin alfa (DARB)
treatment in cancer patients.</strong> American Society of Clinical Oncology, Annual Meeting, Atlanta, GA, June 2-6, 2006. </p>
<p>
Anger JT, Litwin, MS, Wang Q, Chen E,
Pashos CL, Rodríguez LV. <strong>Racial disparities in the surgical management of
stress incontinence among female Medicare beneficiaries. </strong>American Urological Association, Annual Meeting, Atlanta, GA, May 20-25, 2006. </p>
<p>
Anger JT, Rodríguez LV, Wang Q, Pashos CL,
Litwin MS. <strong>High volume providers perform more prolapse repairs
at the time of sling surgery.</strong> American Urological Association, Annual Meeting, Atlanta, GA, May 20-25, 2006. </p>
<p>
Anger JT, Litwin MS, Wang Q, Pashos CL,
Rodríguez LV. <strong>Complications of sling surgery among female Medicare
beneficiaries.</strong> American Urological Association, Annual Meeting, Atlanta, GA, May 20-25, 2006. </p>
<p>
Anger JT, Litwin MS, Wang Q, Pashos CL,
Rodríguez LV. <strong>Variations in stress incontinence and prolapse
management by surgeon specialty.</strong> American Urological Association, Annual Meeting, Atlanta, GA, May 20-25, 2006. </p>
<p>
Lee WC, Balu S, Cobden D, Joshi, AV, Pashos CL. <strong><a href="../downloads/Lee_AdherenceMay06.pdf">A systematic review of adherence with diabetes
treatment and impact of non-adherence on healthcare costs.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 11th Annual International Meeting, Philadelphia, PA, May 20-24, 2006. </p>
<p>
Balu S, Cobden D. Joshi AV, Lee WC, Pashos
CL. <strong><a href="../downloads/Balu_SystematicReviewMay06.pdf">A systematic review of atrophic vaginitis treatment,
duration of therapy, and healthcare costs.</a></strong> International Society for Pharmacoeconomics and
Outcomes Research, 11th Annual International Meeting, Philadelphia, PA, May 20-24, 2006. </p>
<p>
Chavez Y, Atzinger C, Lee WC, Pashos CL. <strong>Gaps in the economic evaluation of prostate cancer.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 11th Annual International Meeting, Philadelphia, PA, May 20-24, 2006. </p>
<p>
Gao X, Outley JK, Botteman M, Spalding J,
Simon JA, Pashos CL. <strong>The economic burden of endometriosis.</strong> American College of Obstetrics and Gynecology, Annual Meeting, Washington, DC, May 6-10, 2006. </p>
<p>
Anger JT, Rodríguez LV, Wang Q, Pashos CL,
Litwin MS. <strong>High volume providers perform more prolapse repairs
at the time of sling surgery.</strong> Society for Urodynamics and Female Urology,
International Society of Pelvic Neuromodulation, Genito-Urinary
Reconstructive Surgery Society, Geriatric Urologic Society, and International
Continence Society, Joint Annual Meeting, Grand Bahama Island, The Bahamas, February 22-25, 2006. </p>
<p>
Anger JT, Litwin MS, Wang Q, Pashos CL,
Rodríguez LV. <strong>Complications of sling surgery among female Medicare
beneficiaries.</strong> Society for Urodynamics and Female Urology,
International Society of Pelvic Neuromodulation, Genito-Urinary
Reconstructive Surgery Society, Geriatric Urologic Society, and International
Continence Society, Joint Annual Meeting, Grand Bahama Island, The Bahamas, February 22-25, 2006. </p>
<p>
Anger JT, Litwin MS, Wang Q, Pashos CL,
Rodríguez LV. <strong>Variations in stress incontinence and prolapse
management by surgeon specialty.</strong> Society for Urodynamics and Female Urology,
International Society of Pelvic Neuromodulation, Genito-Urinary
Reconstructive Surgery Society, Geriatric Urologic Society, and International
Continence Society, Joint Annual Meeting, Grand Bahama Island, The Bahamas, February 22-25, 2006. </p>
<p class="backtotop"><a href="#top">back to top</a></p>
<a name="2005"></a>
<h2>2005</h2>
<p>
Cobden D, Nicklasson L, Pashos C, Lee WC,
Conway D. <strong>Economic analysis of the direct and indirect
post-exposure burden associated with needlestick injury in nurses treating
patients with diabetes mellitus.</strong> American Society of Health-System Pharmacists, 40th Mid-year Clinical Meeting, Las Vegas, NV, December 4-8, 2005. </p>
<p>
Lee WC, Hoffman MS, Arcona S, D’Souza J,
Wang Q, Pashos CL. <strong>Cost of treatment for patients with partial seizure
disorder who are refractory.</strong> American Epilepsy Association, 59th Annual Meeting, Washington, DC, December 2-6, 2005. </p>
<p>
Lee WC, Memisoglu A, Pashos CL. <strong>Challenges of designing prospective and
retrospective compliance studies. </strong>International Society for Pharmacoeconomics and
Outcomes Research, 8th Annual European Congress, Florence, Italy, November 6-8, 2005. </p>
<p>
Lee WC, Christensen MC, Joshi AV, Wang Q,
Pashos CL. <strong>Long-term survival among Medicare beneficiaries with
intracranial hemorrhage.</strong> 18th World Congress of Neurology, Sydney, Australia, November 5-11, 2005. </p>
<p>
Yeh Y, Schaefer C, Kutikova L, Edgell E,
Husbands C, Szende A. <strong>Quality of life in hepatocellular carcinoma: A
review of instruments, disease burden, and quality of life outcomes.</strong> International Society for Quality of Life Research
(ISOQOL), Annual Meeting, San Francisco, CA, October 19-22, 2005. </p>
<p>
Duff S, Yeh Y, Yu E, Woolley J. <strong>The economic impact of etanercept and infliximab
treatment in ankylosing spondylitis.</strong> European Congress of Rheumatology, Annual Meeting, Vienna, Austria, June 8-11, 2005. </p>
<p>
Lee WC. <strong>Cost of therapy for ARV naïve HIV-infected patients:
Fosamprenavir/Ritonavir versus Nelfinavir.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 10th Annual International Meeting, Washington, DC, May 15-18, 2005. </p>
<p>
Botteman MF, Ozminkowski RJ, Wang S,
Pashos CL, Foley DJ, Schaefer K. <strong>Cost effectiveness of longer-term treatment with
eszopiclone 3mg in adults with primary insomnia.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 10th Annual International Meeting, Washington, DC, May 15-18, 2005. </p>
<p>
Pashos CL, Lee JM, Botteman MF, Nicklasson
L, Cobden D. <strong>Needlestick injury in acute care nurses caring for
patients with diabetes mellitus: A retrospective study.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 10th Annual International Meeting, Washington, DC, May 15-18, 2005. </p>
<p class="backtotop"><a href="#top">back to top</a></p>
<a name="2004"></a>
<h2>2004</h2>
<p>
Lee WC, Arcona S, Hoffmann M, Wang Q,
Stephens J, Pashos CL. <strong>Cost associated with persistency among patients with
partial seizure disorder switching to oxcarbazepine monotherapy.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 7th Annual European Congress, Hamburg, Germany, October 24-26, 2004. </p>
<p>
Lee WC, Arcona S, Hoffmann M, Wang Q,
Stephens J, Pashos CL. <strong>Effect of comorbidities on medical care use and cost
among patients with partial seizure disorder.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 7th Annual European Congress, Hamburg, Germany, October 24-26, 2004. </p>
<p>
Smith M, Lee WC, Krupski T, Brandman J,
Wang Q, Botteman M, Pashos CL, Litwin M. <strong>Association between androgen deprivation therapy and
fracture risk: A population-based cohort study in men with non-metastatic
prostate cancer. </strong>American Society of Clinical Oncology, Annual Meeting, New Orleans, LA, June 5-8, 2004. </p>
<p>
Krupski T, Smith M, Lee WC, Pashos C,
Brandman J, Wang Q, Botteman M, Litwin M. <strong>Profile of men with prostate cancer on androgen
deprivation therapy at greatest risk of bone complications.</strong> American Society of Clinical Oncology, Annual Meeting, New Orleans, LA, June 5-8, 2004. </p>
<p>
Lee WC, Tran KT, Stephens JM, Dirani RG,
Pashos CL. <strong>Adherence to oral diabetic drug regimen by racial
group in the Texas Medicaid population. </strong>American Diabetes Association, 64th Annual Scientific Sessions, Orange County Convention Center, Orlando, FL, June 4-8, 2004. </p>
<p>
Grad O, Davis J, Vichare R, Mucha L,
Pashos C, Fastenau J, McKenzie RS, Piech CT. <strong>Dosing and Outcomes Study of
Erythropoiesis-stimulating Therapies - D.O.S.E.</strong> Multinational Association of Supportive Care in
Cancer, Annual Meeting, New Orleans, LA, June 2004. </p>
<p>
Lee WC, Pashos CL. <strong>Using the difference in difference method to
understand outcomes in prostate cancer. </strong>International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004. </p>
<p>
Chavez YE, Lee WC, Botteman MF, Pashos CL. <strong>Cost-effectiveness of diagnostic, staging and
treatment options for melanoma.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004. </p>
<p>
Lee WC, Stephens JM, Tran KT, Wang Q,
Dirani RG, Pashos CL. <strong>The economic burden of type 2 diabetes management by
ethnic group in the Texas Medicaid population.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004. </p>
<p>
Edwards N, Rupnow M, Pashos CL, Botteman
MF, Locklear J, Diamond R. <strong>Cost-effectiveness evaluation of long-acting
risperidone injection.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004. </p>
<p>
Tran KT, Stephens JM, Gold KF, Kimura A,
Pashos CL, Muenzer J. <strong>Development and pilot testing of the Hunter Syndrome
– Functional Outcomes for Clinical Understanding Scale: An instrument
to assess functional health in Hunter Syndrome.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004. </p>
<p>
Tran KT, Gold KF, Stephens JM, Kimura A,
Pashos CL, Muenzer J. <strong>Validation of the Hunter Syndrome – Functional
Outcomes for Clinical Understanding Scale.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004. </p>
<p>
Lee WC, Barlas S, Gold KF, Duong P, Madoo
L, Reddy P, Pashos CL. <strong>Anticipated pain prior to surgery compared to actual
pain in patients undergoing outpatient arthroscopic knee procedures.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004. </p>
<p>
Botteman MF, Lowe FC, Naslund M, Sollano
J, Pashos CL, Litwin M. <strong>A cost comparison analysis of two clinically
uroselective alpha blockers in the treatment of benign prostatic hyperplasia.</strong> International Society for Pharmacoeconomics and
Outcomes Research, 9th Annual International Meeting, Arlington, VA, May 17-19, 2004. </p>
<p>
Krupski TL, Smith M, Lee WC, Pashos C,
Brandman J, Wang Q, Botteman M, Litwin MS. <strong>Fracture risk in men with prostate cancer on
androgen deprivation therapy. </strong>American Urological Association, 99th Annual Meeting, San Francisco, CA, May 8-13, 2004. </p>
<p>
Niren N, Grad O, Sung JC, Law A, Shah NP,
Wang Q. <strong>Impact of atopic dermatitis treatment on quality of
life – Results from the findings in atopic children with eczema study.</strong> American Academy of Dermatology, Annual Meeting, Washington, DC, February 6-11, 2004. </p>
</div>
<!-- FOOTER -->
<div id="footer">
© 2009 Abt Bio-Pharma Solutions, Inc. All rights reserved. | <a href="../privacy/index.html">Privacy Statement</a> | <a href="../privacy/safe.html">Safe Harbor Policy</a></div>
</div><!--close container-->
<!-- POPUP MENUS -->
<div id="popupabout" class="popupmenu">
<p><a href="../about/index.html">About ABS</a></p>
<p><a href="../about/executive.html">Executive Management</a></p>
<p><a href="../about/our.html">Our Locations</a></p></div>
<div id="popupadvantage" class="popupmenu">
<p><a href="../advantage/index.html">Our Advantage</a></p>
<p><a href="../advantage/approach.html">Approach</a></p>
<p><a href="../advantage/experience.html">Experience</a></p></div>
<div id="popupservices" class="popupmenu">
<p><a href="../services/biometrics.html">Biometrics</a></p>
<p><a href="../services/clinical.html">Clinical Trials</a></p>
<p><a href="../services/health.html">Health Economics & Outcomes Research</a></p>
<p><a href="../services/postmarketing.html">Registries and Observational Studies</a></p>
<p><a href="../services/strategic.html">Strategic Commercialization Services</a></p></div>
<div id="popuppub" class="popupmenu">
<p><a href="../pub/publications.html">Publications</a></p>
<p><a href="../pub/presentations.html">Presentations</a></p></div>
<div id="popupnews" class="popupmenu">
<p><a href="../news/index.html">News</a></p>
<p><a href="../news/events.html">Events</a></p></div>
<div id="popupcareers" class="popupmenu">
<p><a href="../careers/index.html">Employment at ABS</a></p>
<p><a href="../careers/current.html">Current Opportunities</a></p>
<p><a href="../careers/benefits.html">Benefits</a></p></div>
<script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
<script type="text/javascript">
try {
var pageTracker = _gat._getTracker("UA-7436309-1");
pageTracker._trackPageview();
} catch(err) {}</script>
</body>
</html>